AI Act
Table of Contents
Chapter I – GENERAL PROVISIONS
Chapter II – PROHIBITED AI PRACTICES
Chapter III – HIGH-RISK AI SYSTEMS
Chapter IV – TRANSPARENCY OBLIGATIONS FOR PROVIDERS AND DEPLOYERS OF CERTAIN AI SYSTEMS
Chapter V – GENERAL-PURPOSE AI MODELS
Chapter VI – MEASURES IN SUPPORT OF INNOVATION
Chapter VII – GOVERNANCE
Chapter VIII – EU DATABASE FOR HIGH-RISK AI SYSTEMS
Chapter IX – POST-MARKET MONITORING, INFORMATION SHARING AND MARKET SURVEILLANCE
Chapter X – CODES OF CONDUCT AND GUIDELINES
Chapter XI – DELEGATION OF POWER AND COMMITTEE PROCEDURE
Chapter XII – PENALTIES
Chapter XIII – FINAL PROVISIONS
Recitals (180)
Annexes
Recital 47
(47) AI systems could have an adverse impact on the health and safety of persons, in particular when such systems operate as safety components of products. Consistent with the objectives of Union harmonisation legislation to facilitate the free movement of products in the internal market and to ensure that only safe and otherwise compliant products find their way into the market, it is important that the safety risks that may be generated by a product as a whole due to its digital components, including AI systems, are duly prevented and mitigated. For instance, increasingly autonomous robots, whether in the context of manufacturing or personal assistance and care should be able to safely operate and performs their functions in complex environments. Similarly, in the health sector where the stakes for life and health are particularly high, increasingly sophisticated diagnostics systems and systems supporting human decisions should be reliable and accurate.